Generics - Actavis

Filter

Current filters:

Actavis

Popular Filters

51 to 75 of 103 results

Actavis confirms plan to acquire Warner Chilcott, in $8.5 billion deal

20-05-2013

US generics major Actavis (NYSE: ACT) revealed today (May 20) that it has entered into a definitive agreement…

ActavisGenericsMergers & AcquisitionsPharmaceuticalWarner ChilcottWomen's Health

Actavis and Warner Chilcott leap on merger talks; possible bid for Adcock Ingram

13-05-2013

US generics major Actavis NYSE: ACT) confirmed on Friday (May 10) that it has entered into early stage…

ActavisAdcock IngramFinancialGenericsMergers & AcquisitionsPharmaceuticalWarner Chilcott

Shire prevails in US Lialda patent dispute with Watson

10-05-2013

Ireland-headquartered drugmaker Shire's (LSE: SHP) subsidiary Shire Development has prevailed in its…

ActavisGastro-intestinalsGenericsLegalLialdaNorth AmericaPatentsPharmaceuticalShireWatson Pharmaceuticals

Proposed sourcing on Supreme Court reverse payment drug patent case; lawyers' views

06-05-2013

Within the next several weeks, the US Supreme Court is expected to hand down a ruling in an important…

ActavisGenericsLegalNorth AmericaPatentsPharmaceutical

Actavis and Valeant report first quarter 2013 results

02-05-2013

US generics drug major Actavis (NYSE: ACT) and Canada's Valeant Pharmaceuticals (TSX: VRX) both presented…

ActavisFinancialGenericsValeant Pharmaceuticals

Actavis in OxyContin patent settlement; Valeant takeover bid "on hold"?

29-04-2013

US generic major Actavis (NYSE: ACT) has entered into an agreement with privately-held Purdue Pharma…

ActavisGenericsMergers & AcquisitionsNeurologicalNorth AmericaOxyContinPatentsPurdue PharmaValeant Pharmaceuticals

Actavis settles with Valeant to launch generic Ziana and Zyclara in USA

11-04-2013

US generics drug major Actavis (NYSE: ACT) has reached settlement agreements with Medicis Pharmaceutical,…

ActavisGenericsMarkets & MarketingNorth AmericaPatentsValeant PharmaceuticalsZiana GelZyclara

AstraZeneca in Crestor patent settlement with Actavis and EGIS Pharma

25-03-2013

Anglo-Swedish drug major AstraZeneca (LSE: AZN) has entered into a settlement agreement in its US patent…

ActavisCardio-vascularCrestorGenericsNorth AmericaPatentsPharmaceuticalrosuvastatinShionogiWatson Pharmaceuticals

Sagent Pharma launches generic Zometa in USA; amends supply deal with Actavis

07-03-2013

Privately-held US specialty pharmaceutical company Sagent Pharmaceuticals has announced the approval…

ActavisGenericsMarkets & MarketingNorth AmericaNovartisOncologyProductionSagent PharmaceuticalsZometa

Actavis confirms patent challenge to Endo's Fortesta

04-03-2013

Generics drug giant Actavis (NYSE: ACT, formerly trading as Watson) has confirmed filing an Abbreviated…

ActavisEndo PharmaceuticalsFortestaGenericsMen's HealthNorth AmericaPatentsRegulation

Lower 4th-qtr 2012 profits at Actavis but beat expectations

19-02-2013

US generics major Actavis (NYSE: ACT, the new name for the Watson business) reported net revenue increased…

ActavisFinancialGenericsWatson Pharmaceuticals

Pfizer prevails in Rapamune patent dispute with Watson

01-02-2013

Global pharma behemoth Pfizer (NYSE: PFE) says that the US District Court for the District of Delaware…

ActavisGenericsImmunologicalsLegalNorth AmericaPatentsPfizerPharmaceuticalRapamuneWatson Pharmaceuticals

51 to 75 of 103 results

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top